STOCK TITAN

Alamar Biosciences grants director RSUs, options

Director Robert P. Ragusa received time-vested RSUs and stock options as equity compensation from Alamar Biosciences.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Alamar Biosciences, Inc. (ALMR) reported that director Robert P. Ragusa received equity awards on September 1, 2026. He was granted 5,686 restricted stock units, which vest in equal annual installments over three years starting September 1, 2026, subject to his continuous service. He also received a stock option for 25,599 shares of common stock at an exercise price of $29.36 per share, expiring August 31, 2036; one-third of these option shares vest on September 1, 2027, with the remainder vesting in equal monthly installments through September 1, 2029, contingent on continued service. Following these grants, he holds 5,686 shares of common stock directly and 25,599 option shares related to this award, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider RAGUSA ROBERT P
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2 25,599 $0.00 $0.00
Grant/Award Common Stock F1 5,686 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 25,599 contracts (Direct); Common Stock — 5,686 shares (Direct)
Footnotes (2)
  1. F1. Represents a restricted stock unit ("RSU") award. The RSUs vest in equal annual installments over 3 years measured from September 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
  2. F2. One-third of the shares subject to the option will vest on September 1, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through September 1, 2029, subject to the reporting person's continuous service as of each such vesting date.
Restricted stock units granted 5,686 units RSU award to director on September 1, 2026
Stock option shares granted 25,599 shares Option grant to director on September 1, 2026
Option exercise price $29.36 per share Exercise price for 25,599-share option expiring August 31, 2036
Option expiration date August 31, 2036 End of exercise period for the granted stock option
RSU vesting period 3 years RSUs vest in equal annual installments from September 1, 2026
Initial option cliff vesting 1/3 on September 1, 2027 First tranche of option shares vesting for the director
Common shares held after RSU grant 5,686 shares Total direct common stock position reported after the RSU award
Option shares held after grant 25,599 shares Total option position from this award following the transaction
restricted stock unit financial
"Represents a restricted stock unit ("RSU") award."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vest financial
"The RSUs vest in equal annual installments over 3 years"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
continuous service financial
"subject to the reporting person's continuous service as of each such vesting date"
exercise price financial
"shares subject to the option will vest on September 1, 2027"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
monthly installments financial
"will vest in equal monthly installments thereafter through September 1, 2029"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

FAQ

What equity awards did ALMR director Robert P. Ragusa receive on September 1, 2026?

He received 5,686 restricted stock units and a stock option for 25,599 shares of Alamar Biosciences common stock, both granted on September 1, 2026 as part of his equity compensation.

How do the 5,686 RSUs granted to the ALMR director vest?

The 5,686 RSUs vest in equal annual installments over 3 years, measured from September 1, 2026, and each installment is subject to Robert P. Ragusa’s continuous service on the applicable vesting date.

What are the key terms of the 25,599-share stock option granted by ALMR?

The option covers 25,599 shares of common stock at an exercise price of $29.36 per share and expires on August 31, 2036, providing long-term potential value if the share price exceeds the exercise price.

How does the stock option for ALMR’s director vest over time?

One-third of the 25,599 option shares vest on September 1, 2027. The remaining shares vest in equal monthly installments through September 1, 2029, conditioned on Robert P. Ragusa’s continuous service.

What are Robert P. Ragusa’s reported ALMR holdings after these awards?

After these grants, he directly holds 5,686 shares of common stock from the RSU award and 25,599 option shares tied to the new stock option, as reported in the filing.

Were Robert P. Ragusa’s ALMR equity awards made under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan for these September 1, 2026 equity awards to Robert P. Ragusa.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RAGUSA ROBERT P

(Last)(First)(Middle)
C/O ALAMAR BIOSCIENCES, INC.
47071 BAYSIDE PARKWAY

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026A(1)5,686A$05,686D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$29.3609/01/2026A25,599 (2)08/31/2036Common Stock25,599$025,599D
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award. The RSUs vest in equal annual installments over 3 years measured from September 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
2. One-third of the shares subject to the option will vest on September 1, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through September 1, 2029, subject to the reporting person's continuous service as of each such vesting date.
/s/ Timothy White, Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)